OCWP
PRME icon

Owl Creek Wealth Partners’s Prime Medicine PRME Stock Holding History

Owl Creek Wealth Partners’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.65K Hold
2,615
– – ﹤0.01% 861
2026
Q1 		$9.1K Buy
+2,615
New +$9.95K ﹤0.01% 814

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Owl Creek Wealth Partners's PRME Position: Q2 2026 in Review

Owl Creek Wealth Partners held its Prime Medicine (PRME) position steady in Q2 2026 at 2,615 shares worth $9.65K. The position accounts for ﹤0.01% of the portfolio, ranked #861.

Owl Creek Wealth Partners first reported a position in PRME in Q1 2026 and has held it in 2 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Owl Creek Wealth Partners held 2,615 shares of Prime Medicine worth $9.65K as of Q2 2026.
  • Owl Creek Wealth Partners left its Prime Medicine share count unchanged in Q2 2026.
  • Prime Medicine made up ﹤0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #861 holding.
  • Owl Creek Wealth Partners first reported a position in Prime Medicine in Q1 2026 and has held it in 2 quarters since.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.